KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) Net Margin (2016 - 2026)

Quest Diagnostics' Net Margin history spans 18 years, with the latest figure at 1.38% for Q1 2026.

  • On a quarterly basis, Net Margin fell 832.0% to 1.38% in Q1 2026 year-over-year; TTM through Mar 2026 was 5.65%, a 203.0% decrease, with the full-year FY2025 number at 8.77%, down 1.0% from a year prior.
  • Net Margin hit 1.38% in Q1 2026 for Quest Diagnostics, down from 7.59% in the prior quarter.
  • Over the last five years, Net Margin for DGX hit a ceiling of 11.64% in Q1 2022 and a floor of 1.38% in Q1 2026.
  • Historically, Net Margin has averaged 7.35% across 5 years, with a median of 7.6% in 2025.
  • Biggest five-year swings in Net Margin: plummeted -1984bps in 2022 and later skyrocketed 382bps in 2023.
  • Tracing DGX's Net Margin over 5 years: stood at 3.26% in 2022, then skyrocketed by 117bps to 7.08% in 2023, then rose by 6bps to 7.48% in 2024, then increased by 2bps to 7.59% in 2025, then plummeted by -118bps to 1.38% in 2026.
  • Business Quant data shows Net Margin for DGX at 1.38% in Q1 2026, 7.59% in Q4 2025, and 7.6% in Q3 2025.